Blockchain Startup Triall introduces a tokenized ecosystem to accelerate and improve medical research - press release

Blockchain Startup Triall introduces a tokenized ecosystem to accelerate and improve medical research - press release

press release. TriALL starts his main utility token TRL at the uniswap after a successful token pre-sale, which earned more than $ 2 million.

Amsterdam, 28.09.2021- Blockchain-startup test version

Modern clinical studies are becoming increasingly complex, lengthy and resource inefficient. Therefore, it usually takes 10 years of clinical studies for a new medication to come onto the market. The exceptionally fast COVID-19 vaccine studies of the past year have shown that there are clear ways to improve the speed and strictness of the clinical study company if interest groups and efforts are coordinated. Triall uses this opportunity by using blockchain and related technologies to secure and rationalize clinical operation.

In the past 3 years, Triall has developed and commercialized its first product Verial ETMF, which enables researchers to anchor research data in the blockchain in order to ensure integrity of clinical studies. The product is already used and recorded in six clinical studies, including an IBS, Autoimmun and Covid 19 vaccine project. Verial ETMF is the first of many blockchain-capable applications that are integrated into a single digital platform: the trial ecosystem.

is a project with global ambitions. The company builds on a fast network in the field of clinical studies that comprises the EU and US regions, and is supported by a global network of partners and consultants, including industry experts and important opinion artists who support Trial in the further expansion of its ecosystem.

Speaking of global ambitions by Trialall: hadil es-sbai , CEO from trial said:

This is the right time for disruptive innovations to demonstrate your added value in clinical operation and find your way to the industry-wide acceptance. Our first product is currently being included in a growing number of clinical studies. will enable faster, more intelligent and more efficient clinical studies. ”

In order to promote the microeconomics of his ecosystem, Trial introduces his most important utility token TRL. This token primarily serves as a means of payment for the software solutions offered in the trial ecosystem, but also enables P2P remuneration, community engagement, governance and loyalty programs (such as membership and staking programs). In the past few months, Triall has worked with several well -known companies in the crypto sector, including LTO Network, Zokyo, Faculty Group, Ferrum Network as well as Trustpad and Prostart Launchpads.

on test version

Bring Web 3.0 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that ensure and rationalize the development of new vaccines and therapeutics during clinical studies. The solutions of Triall make clinical studies in a manipulation and enable secure and efficient integrations between the many isolated systems and parties that are involved in clinical study processes. The Triall software is developed by experts for clinical studies to ensure optimal user experience and to solve the actual weaknesses in the industry.

Further information on how Trial Blockchain uses to revolutionize medical research can be found on your website Style = "font-Weight: 400;"> here .

follow the test version on twitter

step the trial community at telegram

contact details of the media

Contact-email: press@triall.io

test is the source of this content. This press release only serves for information purposes. The information neither represent an investment advice nor an investment offer.


This is a press release. Readers should fulfill their own duty of care before taking any measures in connection with the advertised company or one of its connected companies or services. Bitcoin.com is neither directly nor indirectly responsible for damage or losses caused by or in connection with or in connection with the use or trust in content, goods or services mentioned in the press release.

Bedy verification : Shutterstock, Pixabay, Wiki Commons

Kommentare (0)